[1]
2018. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences. 54, Especial (Dec. 2018), e01005. DOI:https://doi.org/10.1590/s2175-97902018000001005.